The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Signatures to Be Filed for California Drug Price Referendum

Signatures to Be Filed for California Drug Price Referendum

October 30, 2015 • By Sharon Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

SACRAMENTO, Calif. (Reuters)—Backers of a referendum aimed at reducing the cost of prescription drugs in California said Wednesday that they had gathered more than enough signatures to place their measure on the November 2016 ballot in the most populous U.S. state.

You Might Also Like
  • Drug Industry Group Sues to Stop California Drug Price Law
  • Drug Industry on Tenterhooks as Maryland Price-Gouging Law Nears
  • Maryland Lawmakers Approve Bill to Fight Drug Price-Gouging

The measure by the AIDS Healthcare Foundation would require the state to pay no more for prescription medications than does the federal Veterans Administration, which negotiates aggressively with drug companies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“If prices are lower, the burden on taxpayers is going to be lower,” said Michael Weinstein, the organization’s longtime president. “It’s also going to trickle down to the copays and costs of what people pay for pharmaceuticals.”

The Los Angeles-based organization, which provides services to AIDS and HIV patients and is involved in public health advocacy, has collected nearly 550,000 signatures from California voters to place the measure on the ballot, more than the 366,000 valid signatures needed, Weinstein said in an exclusive interview with Reuters.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The group plans to file the signatures with the state on Nov. 2.

The measure is expected to generate fierce opposition from the pharmaceutical industry, which already has a war chest of about $10 million in a campaign account set up to fight it.

According to the state’s campaign finance website, donations include $5.7 million from Johnson & Johnson and $2.8 million from Bristol-Myers Squibb Co.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“While this ballot measure may look simple, the changes being proposed will have adverse consequences for Californians,” said Kathy Fairbanks, spokeswoman for the campaign against the measure.

“If it goes forward we will be preparing a campaign to educate voters in California about its negative consequences.”

Weinstein said the organization had tried for years to persuade the California legislature to adopt laws that would control spiraling pharmaceutical costs in the state, to no avail.

He predicted that anger over high prices for prescription drugs would lead to strong support for the measure. Prices paid by the state would be tied to those negotiated by the Veterans Administration, because the federal agency has negotiated rates for the drugs that it buys that are 20 to 25% lower than most other customers pay.

The organization is also seeking to qualify a similar measure for the ballot in Ohio. Three years ago, it successfully backed a ballot measure requiring adult film actors in Los Angeles to use condoms. The organization is currently backing a statewide version of that measure.

Filed Under: Drug Updates, Legislation & Advocacy, Professional Topics Tagged With: California, costs, drug, Legislation, pharmaceutical company

You Might Also Like:
  • Drug Industry Group Sues to Stop California Drug Price Law
  • Drug Industry on Tenterhooks as Maryland Price-Gouging Law Nears
  • Maryland Lawmakers Approve Bill to Fight Drug Price-Gouging
  • Trump Says Drug Companies to Announce “Massive” Price Cuts Soon

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.